Dual-targeted lipid nanoparticles for TET3 siRNA delivery: nanobiotechnology strategy to remodel tumor immune microenvironment in hepatocellular carcinoma

作者
Wei Peng,J. Zhou,Zhiliang Chen,Chengjia Tang,Jia Cai Kuang,Wenke Li,Zhao Yang
出处
期刊:Journal of Nanobiotechnology [BioMed Central]
卷期号:24 (1)
标识
DOI:10.1186/s12951-026-04312-6
摘要

Hepatocellular carcinoma (HCC) is characterized by a highly immunosuppressive tumor microenvironment (TME), where M2-polarized tumor-associated macrophages (TAMs) and exhausted CD8 + T cells limit immunotherapy efficacy. However, the upstream epigenetic mechanisms driving these phenotypes remain poorly defined, and effective nanotherapeutic strategies to reverse this immunosuppression are lacking. This study aimed to identify key epigenetic regulators of TME dysfunction and develop a targeted nanoplatform to restore antitumor immunity in HCC. Single-cell RNA sequencing identified ten-eleven translocation 3 (TET3) as highly expressed in M2 TAMs in HCC tissues. Mechanistically, TET3 promotes M2 polarization by enhancing interferon regulatory factor 4 (IRF4) transcriptional activity via hydroxymethylation, which in turn induces CD8⁺ T cell exhaustion through the CXCL12/CXCR4 axis. To target this pathway, we engineered dual-targeted lipid nanoparticles (TET3 siRNA@αmp-Lipo) modified with macrophage-specific peptides, enabling efficient and specific delivery of TET3 siRNA to M2 TAMs. In vitro experiments demonstrated the nanoparticles’ excellent biocompatibility, stability, and ability to silence TET3, inhibiting M2 polarization and restoring CD8 + T cell function. In vivo studies confirmed that TET3 siRNA@αmp-Lipo significantly suppressed tumor growth, reduced M2 TAM infiltration, and reversed CD8 + T cell exhaustion in HCC models. This study identifies the TET3–IRF4 axis as a central epigenetic driver of immunosuppression in HCC and establishes TET3 siRNA@αmp-Lipo as a potent and translatable nanobiotechnology platform. By integrating targeted siRNA delivery with immune microenvironment remodeling, this strategy provides a promising approach to enhance immunotherapy for HCC and potentially other cancers with immunosuppressive TMEs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
homie完成签到 ,获得积分10
2秒前
忧郁的若菱完成签到 ,获得积分10
2秒前
小艾同学发布了新的文献求助10
3秒前
慕青的应助被ZJPPPP采纳,获得10
3秒前
4秒前
4秒前
隐形曼青的应助被xinyi采纳,获得10
4秒前
学术废物完成签到,获得积分10
4秒前
爱听歌的睫毛完成签到,获得积分10
5秒前
dd发布了新的文献求助10
5秒前
鲸落小小的应助被可妍昇采纳,获得10
6秒前
yosh发布了新的文献求助10
6秒前
chen7402完成签到,获得积分10
6秒前
7秒前
7秒前
多加辣完成签到,获得积分10
7秒前
ruiruirui完成签到,获得积分10
8秒前
英姑的应助被yu采纳,获得10
9秒前
王懒懒完成签到 ,获得积分10
10秒前
烟花的应助被风中的宛白采纳,获得10
10秒前
勤奋一一的应助被科研通管家采纳,获得10
11秒前
开朗紫发布了新的文献求助10
11秒前
NexusExplorer的应助被科研通管家采纳,获得10
11秒前
Lucas的应助被科研通管家采纳,获得10
11秒前
陈心如发布了新的文献求助30
11秒前
FashionBoy的应助被科研通管家采纳,获得10
11秒前
隐形曼青的应助被科研通管家采纳,获得10
12秒前
aqqq的应助被科研通管家采纳,获得10
12秒前
曾维嘉完成签到,获得积分10
12秒前
12秒前
隐形曼青的应助被科研通管家采纳,获得10
12秒前
feifei完成签到,获得积分10
12秒前
12秒前
搜集达人的应助被科研通管家采纳,获得10
12秒前
领导范儿的应助被科研通管家采纳,获得10
12秒前
爆米花的应助被科研通管家采纳,获得10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181460
求助须知:如何正确求助?哪些是违规求助? 9571362
关于积分的说明 21817839
捐赠科研通 7777938
什么是DOI,文献DOI怎么找? 3433494
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479550